CONTENTS:
- Medical cannabis in Arizona: patient characteristics, perceptions, and impressions of medical cannabis legalization. Troutt W.D., DiDonato M.D., p. 259-266.
- Patterns and perceptions of dextromethorphan use in adult members of an online dextromethorphan community. Pringle G., McDonald M.P., Gabriel K.I., p. 267-275.
- Long-term ketamine self-injections in major depressive disorder: Focus on tolerance in ketamine's antidepressant response and the development of ketamine addiction. Bonnet U., p. 276-285.
- The association of Salvia divinorum and psychotic disorders: A review of the literature and case series. El-Khoury J., Sahakian N., p. 286-292.
- Attitudes toward substance abuse clients: An empirical study of clinical psychology trainees. Mundon C.R., Anderson M.L., Najavits L.M., p. 293-300.
- Staff views of acceptability and appropriateness of a computer-delivered brief intervention for moderate drug and alcohol use. Mitchell S.G., Monico L.B., Gryczynski J., O'Grady K.E., Schwartz R.P., p. 301-307.
- What social bonds have the greatest influence on patterns of substance use among child-welfare-involved youth? Snyder S.M., Gwaltney A.Y., Landeck E., p. 308-316.
- Predictors of relapse and dropout during a 12-week relapse prevention program for methamphetamine users. Chen Y.-C., Chen C.-K., Wang L.-J., p. 317-324.
- Evaluating the effects of varenicline on craving, withdrawal, and affect in a randomized, double-blind, placebo-controlled clinical trial of varenicline for smokeless tobacco dependence in India. Jhanjee S., Jain R., Jain V., Gupta T., Mittal S., Goelz P., et al., p. 325-330.
- Biochemical validation of self-reported smokeless tobacco abstinence among smokeless tobacco users: Results from a clinical trial of varenicline in India. Jain R., Jhanjee S., Jain V., Gupta T., Mittal S., Chauhan P., et al., p. 331-335.